Article
Licensed
Unlicensed
Requires Authentication
The transformative role of GLP-1 receptor agonists in obesity and chronic disease: clinical insights from a dialogue with artificial intelligence
-
Rahi Gandhi
Published/Copyright:
January 8, 2026
Received: 2025-12-04
Accepted: 2025-12-27
Published Online: 2026-01-08
© 2026 Walter de Gruyter GmbH, Berlin/Boston
You are currently not able to access this content.
You are currently not able to access this content.
Keywords for this article
GLP-1 receptor agonists;
artificial intelligence;
obesity;
cardiometabolic disease;
clinical decision-making
